Fagiuoli, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 555
EU - Europa 344
AS - Asia 153
SA - Sud America 11
AF - Africa 3
Totale 1.066
Nazione #
US - Stati Uniti d'America 550
SE - Svezia 98
IT - Italia 74
CN - Cina 62
DE - Germania 62
SG - Singapore 48
IE - Irlanda 25
FR - Francia 19
UA - Ucraina 19
ID - Indonesia 14
FI - Finlandia 12
GB - Regno Unito 11
BR - Brasile 10
TR - Turchia 8
RU - Federazione Russa 7
IN - India 6
NL - Olanda 5
AT - Austria 4
BZ - Belize 4
JP - Giappone 4
CZ - Repubblica Ceca 2
HK - Hong Kong 2
KR - Corea 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BE - Belgio 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MX - Messico 1
NG - Nigeria 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
Totale 1.066
Città #
Chandler 88
Houston 55
Ashburn 54
Redmond 45
Singapore 43
Rome 33
Chicago 27
Dublin 25
Nanjing 15
San Mateo 15
Jakarta 14
Jacksonville 13
Wilmington 13
New York 11
Paris 10
San Jose 10
Boston 9
Cattolica 9
Dearborn 8
Helsinki 8
Milan 8
Princeton 7
Las Vegas 6
Ann Arbor 5
Izmir 5
Los Angeles 5
Seattle 5
Zhengzhou 5
Belize City 4
Lawrence 4
Marseille 4
Moscow 4
Shenyang 4
Simi Valley 4
Woodbridge 4
Albuquerque 3
Beijing 3
Bologna 3
Capelle 3
Changsha 3
Fairfield 3
London 3
Nanchang 3
Norwalk 3
Tokyo 3
Boardman 2
Cambridge 2
Columbus 2
Falkenstein 2
Fremont 2
Hebei 2
Jiaxing 2
Kunming 2
Montes Claros 2
Mountain View 2
Munich 2
Nuremberg 2
Redwood City 2
Seoul 2
São Paulo 2
Tianjin 2
Vienna 2
Abidjan 1
Almaty 1
Amsterdam 1
Andover 1
Augusta 1
Bangalore 1
Bari 1
Bishkek 1
Brdo 1
Bremen 1
Brno 1
Brussels 1
Buenos Aires 1
Buffalo 1
Changchun 1
Dubai 1
Gavirate 1
Guangzhou 1
Hangzhou 1
Hefei 1
Hong Kong 1
Jerusalem 1
Jinan 1
Jingmen 1
Katerini 1
Kocaeli 1
Lagos 1
Lanzhou 1
Mandaluyong City 1
Mexico City 1
Mumbai 1
Orange 1
Perugia 1
Piacenza 1
Pittsburgh 1
Riga 1
Saint Louis 1
San Giorgio di Piano 1
Totale 681
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 213
Gut microbiota in autism and mood disorders 141
Gut microbiota in autism and mood disorders 117
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 94
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 76
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 74
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 70
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 66
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 54
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use 45
Real life experiences in HCV management in 2018 41
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 38
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 22
Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D-MELD With Particular Reference to HCV Recipients 21
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 16
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 15
Totale 1.103
Categoria #
all - tutte 4.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 0 0 2 7 3 9 20
2020/2021101 14 6 8 7 6 5 2 5 21 9 14 4
2021/2022105 10 3 3 5 9 5 1 16 5 6 24 18
2022/2023274 29 39 19 28 20 32 9 33 41 10 6 8
2023/2024142 8 34 5 5 10 12 4 37 2 5 8 12
2024/2025137 5 3 26 19 31 22 24 7 0 0 0 0
Totale 1.103